top penny stocks news headlines

If you’re looking for the best penny stocks to buy right now, news headlines may be a good place to look. While there’s no guarantee that good news will be “good” for a stock, more times than not, it can act as an immediate catalyst. Things like unusual options volume, insider trading activity, and short data might be more challenging to identify. But the news is usually front and center, with very minimal effort necessary to find it.

The real trick is when it comes time to know how to use it to your advantage. In this article, we look at a handful of penny stocks with news this week. The latest round of headlines has sparked serious interest in these companies. But like discussed above, “good” news doesn’t always mean stocks go up, and “bad” news doesn’t always mean the opposite.

So let’s look at what’s going on in the stock market today and what announcements are hitting the wires, and then you can decide if these deserve a place on your list of penny stocks to watch.

Penny Stocks to Watch

Veru Inc. (VERU)

penny stocks to buy Veru Inc VERU stock

What Does Veru Inc. Do?

Veru Is a biotech company developing oncology medications and other compounds targeting viral diseases, including SARS-CoV-2.

VERU Stock News

This week the company announced the sale of its ENTADFI business for $20 million. It also comes with a rider for up to another $80 million based on sales milestones.

“The sale of ENTADFI and revenues from our FC2 business provide Veru with financial flexibility and resources to advance our important drug candidates, enobosarm for 2nd line AR+ ER+ HER2- metastatic breast cancer and sabizabulin for SARS-CoV-2 viral ARDS, that could yield Phase 3 clinical trial data in 2024,” said Veru CEO Mitchell Steiner, M.D.

Aditxt Inc. (ADTX)

penny stocks to buy Aditxt ADTX stock

What Does Aditxt Inc. Do?

Aditxt is another biotechnology company. However, unlike Veru, it focuses on candidates that monitor and modulate immune system responses. For instance, its portfolio company, Adimune Inc., provides specific platforms for addressing organ rejection, autoimmunity, and allergies. Aditxt also has a business unit, Adivir, focused on new ways to treat infectious diseases.

Penny Stock Risk Assessment: Evaluating Potential Investments

ADTX Stock News

This week Aditxt announced the signing of an asset purchase agreement with Cellvera. The deal allows Aditxt 50% ownership in G Response Aid FZE. The deal’s significance is that G Response has an exclusive worldwide (excluding Japan, China, and Russia) license to Avigan.

CEO Amro Albanna explained, “We believe that Avigan can play a vital role in the treatment of a range of infectious diseases due to the broad-spectrum nature of the molecule. Although we have only recently entered into the therapeutics market, our goal is to drive a paradigm shift in the treatment and prevention of infectious diseases globally through our newly formed subsidiary Adivir.”

TeraWulf Inc. (WULF)

penny stocks to buy TeraWulf WULF stock

What Does TeraWulf Inc. Do?

TeraWulf is a Bitcoin mining facility operator focused on low-carbon energy production.

WULF Stock News

Thanks to a rebound in Bitcoin prices, related stocks have caught a reprieve from the latest round of selling. In addition, TeraWulf announced this week that it would participate in a series of investor events through the end of April and into May. This, coupled with underlying industry momentum, seems to be a focus for traders in the stock market today. If WULF stock is on your list, the first of these events is on April 25th during the Sequire Investor Summit.

4 Penny Stocks To Buy According To Analysts, Targets Up To 1,560%

Recruiter . com Group Inc. (RCRT)

penny stocks to buy Recruiter.com RCRT stock

What Does Recruiter . com Group Inc. Do?

Recruiter . com Group offers an on-demand recruiting platform for talent acquisition from hiring companies.

RCRT Stock News

This week, the company launched its AI-driven Candidate Pitch platform. The company has chosen OpenAi’s ChatGPT to power the application, which can convert resumes into career profiles. Recruiters and job seekers can create text-based summaries that show off bespoke skills and experience.

Evan Sohn, CEO of Recruiter.com, explained, “At Recruiter.com, our mission is to provide scalable talent acquisition solutions that drive results for organizations of all sizes, from startups to Fortune 100 companies. Candidate Pitch is just the beginning; we are streamlining the hiring process for job seekers and recruiters by leveraging OpenAI technologies’ power to craft compelling career summaries that set our users apart.”

Clearmind Medicine Inc. (CMND)

What Does Clearmind Medicine Inc. Do?

penny stocks to buy Clearmind Medicine CMND stock

Clearmind develops psychedelic-derived treatment candidates. The company has an IP portfolio of 14 patent families and has highlighted alcohols use disorder as one of the targets of its treatment platform.

CMND Stock News

CMND stock is trading higher this week after the company engaged a contract research organization to support a first-in-human trial. Its CMND-100 will be evaluated in treating alcohol use disorder with the CRO acting as the project manager.

Penny Stocks To Buy? 7 Under $1 To Watch This Week

List Of Penny Stocks With News


Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom
Privacy Policy

Midam Ventures, LLC | (305) 306-3854 | 1501 Venera Ave, Coral Gables, FL 33146 | news@pennystocks.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Penny Stocks On Robinhood To Buy Under $1 In January 2021

Should You Buy Penny Stocks Under $1 Right Now?

3 High Volume Penny Stocks To Watch This Week

Are These High Volume Penny Stocks On You Watch List Today?

What Are The Best Penny Stocks To Buy If You Like Biotech? 3 To Watch

Are These Biotech Penny Stocks To Buy Or Avoid After Monday’s Session?